Press Releases

    Print Page  Close Window
BioMed Realty Trust Announces Tax Treatment of 2005 Distributions

SAN DIEGO, Jan. 26 /PRNewswire-FirstCall/ -- BioMed Realty Trust, Inc. (NYSE: BMR) today announced the tax treatment of its 2005 distributions as follows:

                      Security Description: Common Stock
                               CUSIP: 09063H107
                              Ticker Symbol: BMR

                                       Total                         Taxable
                                    Distribution     Allocable       Ordinary
    Record Date      Payable Date    Per Share        to 2005        Dividend

    12/31/2004       1/14/2005       $0.270000       $0.136027       $0.136027
    3/31/2005        4/15/2005       $0.270000       $0.270000       $0.270000
    6/15/2005        7/15/2005       $0.270000       $0.270000       $0.270000
    9/30/2005        10/17/2005      $0.270000       $0.270000       $0.270000
    12/30/2005       1/16/2006       $0.270000       $0.064278       $0.064278
              Totals                 $1.350000       $1.010305       $1.010305

The company did not incur any foreign taxes during 2005. In addition, only for purposes of calculating alternative minimum taxable income under Section 55 of the Internal Revenue Code of 1986, as amended, the company apportions $0.017 per share attributable to depreciation, assuming a full year of ownership. Stockholders are encouraged to consult with their personal tax advisors as to their specific tax treatment of BioMed Realty Trust distributions.

About BioMed Realty Trust

BioMed Realty Trust, Inc. is a real estate investment trust (REIT) focused on acquiring, developing, owning, leasing and managing laboratory and office space for the life science industry. The company's tenants include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry, and its current properties and primary acquisition targets are located in markets with well established reputations as centers for scientific research, including Boston, San Diego, San Francisco, Seattle, Maryland, Pennsylvania and New York/New Jersey. Additional information is available at

SOURCE BioMed Realty Trust, Inc.
CONTACT: John F. Wilson, II, Chief Financial Officer of BioMed Realty Trust, Inc., +1-858-485-9840
Web site:
01/26/2006 20:46 EST